{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T13:28:20Z","timestamp":1769606900080,"version":"3.49.0"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2020,5,28]],"date-time":"2020-05-28T00:00:00Z","timestamp":1590624000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,5,28]],"date-time":"2020-05-28T00:00:00Z","timestamp":1590624000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Psychiatry"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1038\/s41380-020-0794-5","type":"journal-article","created":{"date-parts":[[2020,5,28]],"date-time":"2020-05-28T10:03:09Z","timestamp":1590660189000},"page":"5899-5911","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Allosteric modulation of AMPA receptors counteracts Tau-related excitotoxic synaptic signaling and memory deficits in stress- and A\u03b2-evoked hippocampal pathology"],"prefix":"10.1038","volume":"26","author":[{"given":"Daniela","family":"Monteiro-Fernandes","sequence":"first","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8257-3413","authenticated-orcid":false,"given":"Joana Margarida","family":"Silva","sequence":"additional","affiliation":[]},{"given":"Carina","family":"Soares-Cunha","sequence":"additional","affiliation":[]},{"given":"Christina","family":"Dalla","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5081-3382","authenticated-orcid":false,"given":"Nikolaos","family":"Kokras","sequence":"additional","affiliation":[]},{"given":"Fran\u00e7ois","family":"Arnaud","sequence":"additional","affiliation":[]},{"given":"Rodolphe","family":"Billiras","sequence":"additional","affiliation":[]},{"given":"Viktoriya","family":"Zhuravleva","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4263-5576","authenticated-orcid":false,"given":"Clarissa","family":"Waites","sequence":"additional","affiliation":[]},{"given":"Sylvie","family":"Bretin","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8755-5126","authenticated-orcid":false,"given":"Nuno","family":"Sousa","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0115-0038","authenticated-orcid":false,"given":"Ioannis","family":"Sotiropoulos","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2020,5,28]]},"reference":[{"key":"794_CR1","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1126\/science.1132814","volume":"314","author":"M Goedert","year":"2006","unstructured":"Goedert M, Spillantini MG. A century of Alzheimer\u2019s disease. Science. 2006;314:777\u201381.","journal-title":"Science."},{"key":"794_CR2","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s00401-009-0532-1","volume":"118","author":"C Duyckaerts","year":"2009","unstructured":"Duyckaerts C, Delatour B, Potier MC. Classification and basic pathology of Alzheimer disease. Acta Neuropathol. 2009;118:5\u201336.","journal-title":"Acta Neuropathol."},{"key":"794_CR3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1101\/cshperspect.a006189","volume":"1","author":"A Serrano-Pozo","year":"2011","unstructured":"Serrano-Pozo A, Frosch MP, Masliah E, Hyman BT. Neuropathological alterations in Alzheimer disease. Cold Spring Harb Perspect Med. 2011;1:1\u201323.","journal-title":"Cold Spring Harb Perspect Med"},{"key":"794_CR4","doi-asserted-by":"crossref","first-page":"4012","DOI":"10.1073\/pnas.0811698106","volume":"106","author":"RM Koffie","year":"2009","unstructured":"Koffie RM, Meyer-Luehmann M, Hashimoto T, Adams KW, Mielke ML, Garcia-Alloza M, et al. Oligomeric amyloid beta associates with postsynaptic densities and correlates with excitatory synapse loss near senile plaques. Proc Natl Acad Sci USA. 2009;106:4012\u20137.","journal-title":"Proc Natl Acad Sci USA"},{"key":"794_CR5","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.neuron.2014.10.038","volume":"84","author":"R Sperling","year":"2014","unstructured":"Sperling R, Mormino E, Johnson K. The evolution of preclinical Alzheimer\u2019s disease: Implications for prevention trials. Neuron. 2014;84:608\u201322.","journal-title":"Neuron."},{"key":"794_CR6","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1016\/j.neurobiolaging.2005.09.012","volume":"27","author":"SW Scheff","year":"2006","unstructured":"Scheff SW, Price DA, Schmitt FA, Mufson EJ. Hippocampal synaptic loss in early Alzheimer\u2019s disease and mild cognitive impairment. Neurobiol Aging. 2006;27:1372\u201384.","journal-title":"Neurobiol Aging."},{"key":"794_CR7","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1038\/nm.2886","volume":"18","author":"HJ Kang","year":"2012","unstructured":"Kang HJ, Voleti B, Hajszan T, Rajkowska G, Stockmeier CA, Licznerski P, et al. Decreased expression of synapse-related genes and loss of synapses in major depressive disorder. Nat Med. 2012;18:1413\u20137.","journal-title":"Nat Med."},{"key":"794_CR8","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/nrn3138","volume":"13","author":"M Popoli","year":"2011","unstructured":"Popoli M, Yan Z, McEwen B, Sanacora G. The stressed synapse: the impact of stress and glucocorticoids on glutamate transmission. Nat Rev Neurosci. 2011;13:22\u201337.","journal-title":"Nat Rev Neurosci"},{"key":"794_CR9","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/j.neubiorev.2008.05.007","volume":"32","author":"I Sotiropoulos","year":"2008","unstructured":"Sotiropoulos I, Cerqueira JJ, Catania C, Takashima A, Sousa N, Almeida OFX. Stress and glucocorticoid footprints in the brain\u2014the path from depression to Alzheimer\u2019s disease. Neurosci Biobehav Rev. 2008;32:1161\u201373.","journal-title":"Neurosci Biobehav Rev"},{"key":"794_CR10","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.biopsych.2005.06.017","volume":"59","author":"E Elgh","year":"2006","unstructured":"Elgh E, Lindqvist Astot A, Fagerlund M, Eriksson S, Olsson T, N\u00e4sman B. Cognitive dysfunction, hippocampal atrophy and glucocorticoid feedback in Alzheimer\u2019s disease. Biol Psychiatry. 2006;59:155\u201361.","journal-title":"Biol Psychiatry."},{"key":"794_CR11","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s11920-009-0007-z","volume":"11","author":"M Simard","year":"2009","unstructured":"Simard M, Hudon C, van Reekum R. Psychological distress and risk for dementia. Curr Psychiatry Rep. 2009;11:41\u20137.","journal-title":"Curr Psychiatry Rep"},{"key":"794_CR12","doi-asserted-by":"crossref","first-page":"9047","DOI":"10.1523\/JNEUROSCI.2797-06.2006","volume":"26","author":"KN Green","year":"2006","unstructured":"Green KN, Billings LM, Roozendaal B, McGaugh JL, LaFerla FM. Glucocorticoids increase amyloid-\u03b2 and Tau pathology in a mouse model of Alzheimer\u2019s Disease. J Neurosci. 2006;26:9047\u201356.","journal-title":"J Neurosci."},{"key":"794_CR13","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1096\/fj.05-4265fje","volume":"20","author":"YH Jeong","year":"2006","unstructured":"Jeong YH, Park CH, Yoo J, Shin KY, Ahn S-M, Kim H-S, et al. Chronic stress accelerates learning and memory impairments and increases amyloid deposition in APPV717I-CT100 transgenic mice, an Alzheimer\u2019s disease model. FASEB J. 2006;20:729\u201331.","journal-title":"FASEB J."},{"key":"794_CR14","doi-asserted-by":"crossref","first-page":"7840","DOI":"10.1523\/JNEUROSCI.0730-11.2011","volume":"31","author":"I Sotiropoulos","year":"2011","unstructured":"Sotiropoulos I, Catania C, Pinto LG, Silva R, Pollerberg GE, Takashima A, et al. Stress acts cumulatively to precipitate Alzheimer\u2019s disease-like Tau pathology and cognitive deficits. J Neurosci. 2011;31:7840\u20137.","journal-title":"J Neurosci."},{"key":"794_CR15","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1038\/s41418-018-0217-1","volume":"26","author":"JM Silva","year":"2019","unstructured":"Silva JM, Rodrigues S, Sampaio-Marques B, Gomes P, Neves-Carvalho A, Dioli C, et al. Dysregulation of autophagy and stress granule-related proteins in stress-driven Tau pathology. Cell Death Differ. 2019;26:1411\u201327.","journal-title":"Cell Death Differ"},{"key":"794_CR16","doi-asserted-by":"crossref","first-page":"131","DOI":"10.14336\/AD.2014.0423","volume":"6","author":"CC Rudy","year":"2015","unstructured":"Rudy CC, Hunsberger HC, Weitzner DS, Reed MN. The role of the tripartite glutamatergic synapse in the pathophysiology of Alzheimer\u2019s disease. Aging Dis. 2015;6:131\u201348.","journal-title":"Aging Dis."},{"key":"794_CR17","doi-asserted-by":"crossref","first-page":"11","DOI":"10.31887\/DCNS.2013.15.1\/jhenley","volume":"15","author":"JM Henley","year":"2013","unstructured":"Henley JM, Wilkinson KA. AMPA receptor trafficking and the mechanisms underlying synaptic plasticity and cognitive aging. Dialogues Clin Neurosci. 2013;15:11\u201327.","journal-title":"Dialogues Clin Neurosci"},{"key":"794_CR18","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.neuropharm.2019.01.010","volume":"149","author":"SL Lesuis","year":"2019","unstructured":"Lesuis SL, Lucassen PJ, Krugers HJ. Early life stress impairs fear memory and synaptic plasticity; a potential role for GluN2B. Neuropharmacol. 2019;149:195\u2013203.","journal-title":"Neuropharmacol"},{"key":"794_CR19","doi-asserted-by":"crossref","first-page":"97","DOI":"10.3233\/JAD-2007-11113","volume":"11","author":"CP Jacob","year":"2007","unstructured":"Jacob CP, Koutsilieri E, Bartl J, Neuen-Jacob E, Arzberger T, Zander N, et al. Alterations in expression of glutamatergic transporters and receptors in sporadic Alzheimer\u2019s disease. JAD. 2007;11:97\u2013116.","journal-title":"JAD"},{"key":"794_CR20","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/6374","volume":"2","author":"PF Chapman","year":"1999","unstructured":"Chapman PF, White GL, Jones MW, Cooper-Blacketer D, Marshall VJ, Irizarry M, et al. Impaired synaptic plasticity and learning in aged amyloid precursor protein transgenic mice. Nat Neurosci. 1999;2:271\u20136.","journal-title":"Nat Neurosci."},{"key":"794_CR21","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.neuron.2006.10.035","volume":"52","author":"H Hsieh","year":"2006","unstructured":"Hsieh H, Boehm J, Sato C, Iwatsubo T, Tomita T, Sisodia S, et al. AMPAR removal underlies abeta-induced synaptic depression and dendritic spine loss. Neuron. 2006;52:831\u201343.","journal-title":"Neuron."},{"key":"794_CR22","doi-asserted-by":"crossref","first-page":"2866","DOI":"10.1523\/JNEUROSCI.4970-06.2007","volume":"27","author":"GM Shankar","year":"2007","unstructured":"Shankar GM, Bloodgood BL, Townsend M, Walsh DM, Selkoe DJ, Sabatini BL. Natural oligomers of the Alzheimer amyloid-protein induce reversible synapse loss by modulating an NMDA-Type glutamate receptor-dependent signaling pathway. J Neurosci. 2007;27:2866\u201375.","journal-title":"J Neurosci."},{"key":"794_CR23","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1523\/JNEUROSCI.4456-09.2010","volume":"30","author":"H-Y Wu","year":"2010","unstructured":"Wu H-Y, Hudry E, Hashimoto T, Kuchibhotla K, Rozkalne A, Fan Z, et al. Amyloid beta induces the morphological neurodegenerative triad of spine loss, dendritic simplification, and neuritic dystrophies through calcineurin activation. J Neurosci. 2010;30:2636\u201349.","journal-title":"J Neurosci."},{"key":"794_CR24","doi-asserted-by":"crossref","first-page":"11938","DOI":"10.1523\/JNEUROSCI.2357-10.2010","volume":"30","author":"H Zempel","year":"2010","unstructured":"Zempel H, Thies E, Mandelkow E, Mandelkow E-M. A oligomers cause localized Ca2+ elevation, missorting of endogenous Tau into dendrites, Tau phosphorylation, and destruction of microtubules and spines. J Neurosci. 2010;30:11938\u201350.","journal-title":"J Neurosci."},{"key":"794_CR25","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.cell.2010.06.036","volume":"142","author":"LM Ittner","year":"2010","unstructured":"Ittner LM, Ke YD, Delerue F, Bi M, Gladbach A, van Eersel J, et al. Dendritic function of tau mediates amyloid-beta toxicity in Alzheimer\u2019s disease mouse models. Cell. 2010;142:387\u201397.","journal-title":"Cell."},{"key":"794_CR26","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1159\/000440844","volume":"16","author":"I Sotiropoulos","year":"2016","unstructured":"Sotiropoulos I, Sousa N. Tau as the converging protein between chronic stress and Alzheimer\u2019s disease synaptic pathology. Neurodegener Dis. 2016;16:22\u20135.","journal-title":"Neurodegener Dis."},{"key":"794_CR27","doi-asserted-by":"crossref","first-page":"4288","DOI":"10.1523\/JNEUROSCI.0406-05.2005","volume":"25","author":"C-H Yang","year":"2005","unstructured":"Yang C-H, Huang C-C, Hsu K-S. Behavioral stress enhances hippocampal CA1 long-term depression through the blockade of the glutamate uptake. J Neurosci. 2005;25:4288\u201393.","journal-title":"J Neurosci."},{"key":"794_CR28","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.neuropharm.2019.02.023","volume":"150","author":"SL Lesuis","year":"2019","unstructured":"Lesuis SL, Kaplick PM, Lucassen PJ, Krugers HJ. Treatment with the glutamate modulator riluzole prevents early life stress-induced cognitive deficits and impairments in synaptic plasticity in APPswe\/PS1dE9 mice. Neuropharmacol. 2019;150:175\u201383.","journal-title":"Neuropharmacol"},{"key":"794_CR29","doi-asserted-by":"crossref","first-page":"E3755","DOI":"10.1073\/pnas.1600953113","volume":"113","author":"S Lopes","year":"2016","unstructured":"Lopes S, Vaz-Silva J, Pinto V, Dalla C, Kokras N, Bedenk B, et al. Tau protein is essential for stress-induced brain pathology. Proc Nat Acad Sci USA. 2016;113:E3755\u201363.","journal-title":"Proc Nat Acad Sci USA."},{"key":"794_CR30","doi-asserted-by":"crossref","first-page":"4745","DOI":"10.1007\/s12035-015-9356-2","volume":"53","author":"S Pinheiro","year":"2016","unstructured":"Pinheiro S, Silva J, Mota C, Vaz-Silva J, Veloso A, Pinto V, et al. Tau mislocation in glucocorticoid-triggered hippocampal pathology. Mol Neurobiol. 2016;53:4745\u201353.","journal-title":"Mol Neurobiol."},{"key":"794_CR31","first-page":"205","volume":"177","author":"RDS Prediger","year":"2007","unstructured":"Prediger RDS, Franco JL, Pandolfo P, Medeiros R, Duarte FS, Di Giunta G, et al. Differential susceptibility following \u03b2-amyloid peptide-(1-40) administration in C57BL\/6 and Swiss albino mice: evidence for a dissociation between cognitive deficits and the glutathione system response. Behav. Brain Res. 2007;177:205\u201313.","journal-title":"Brain Res."},{"key":"794_CR32","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/sj.mp.4002101","volume":"14","author":"C Catania","year":"2009","unstructured":"Catania C, Sotiropoulos I, Silva R, Onofri C, Breen KC, Sousa N, et al. The amyloidogenic potential and behavioral correlates of stress. Mol Psychiatry. 2009;14:95\u2013105.","journal-title":"Mol Psychiatry."},{"key":"794_CR33","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0165-0270(03)00187-0","volume":"130","author":"A Graziano","year":"2003","unstructured":"Graziano A, Petrosini L, Bartoletti A. Automatic recognition of explorative strategies in the Morris water maze. J Neurosci Methods. 2003;130:33\u201344.","journal-title":"J Neurosci Methods"},{"key":"794_CR34","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/j.neuron.2010.11.030","volume":"68","author":"BR Hoover","year":"2010","unstructured":"Hoover BR, Reed MN, Su J, Penrod RD, Kotilinek LA, Grant MK, et al. Tau mislocalization to dendritic spines mediates synaptic dysfunction independently of neurodegeneration. Neuron. 2010;68:1067\u201381.","journal-title":"Neuron."},{"key":"794_CR35","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/nrn1368","volume":"5","author":"MW Salter","year":"2004","unstructured":"Salter MW, Kalia LV. Src kinases: a hub for NMDA receptor regulation. Nat Rev Neurosci. 2004;5:317\u201328.","journal-title":"Nat Rev Neurosci"},{"key":"794_CR36","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.trci.2018.03.009","volume":"4","author":"J Cummings","year":"2018","unstructured":"Cummings J, Lee G, Ritter A, Zhong K. Alzheimer\u2019s disease drug development pipeline: 2018. Alzheimers Dement (N. Y). 2018;4:195\u2013214.","journal-title":"Alzheimers Dement (N. Y)"},{"key":"794_CR37","doi-asserted-by":"crossref","first-page":"e99084","DOI":"10.15252\/embj.201899084","volume":"37","author":"J Vaz\u2010Silva","year":"2018","unstructured":"Vaz\u2010Silva J, Gomes P, Jin Q, Zhu M, Zhuravleva V, Quintremil S, et al. Endolysosomal degradation of Tau and its role in glucocorticoid\u2010driven hippocampal malfunction. EMBO J. 2018;37:e99084.","journal-title":"EMBO J"},{"key":"794_CR38","doi-asserted-by":"crossref","first-page":"763","DOI":"10.3233\/JAD-140693","volume":"43","author":"I Sotiropoulos","year":"2015","unstructured":"Sotiropoulos I, Silva JMGM, Kimura T, Rodrigues AJ, Costa PS, Almeida OFX, et al. Female hippocampus vulnerability to environmental stress, a precipitating factor in tau aggregation pathology. J Alzheimers Dis. 2015;43:763\u201374.","journal-title":"J Alzheimers Dis"},{"key":"794_CR39","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/s41582-018-0116-6","volume":"15","author":"F Panza","year":"2019","unstructured":"Panza F, Lozupone M, Logroscino G, Imbimbo BP. A critical appraisal of amyloid-\u03b2-targeting therapies for Alzheimer disease. Nat Rev Neurol. 2019;15:73\u201388.","journal-title":"Nat Rev Neurol"},{"key":"794_CR40","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/nature20587","volume":"540","author":"HF Iaccarino","year":"2016","unstructured":"Iaccarino HF, Singer AC, Martorell AJ, Rudenko A, Gao F, Gillingham TZ, et al. Gamma frequency entrainment attenuates amyloid load and modifies microglia. Nature. 2016;540:230\u20135.","journal-title":"Nature."},{"key":"794_CR41","doi-asserted-by":"crossref","first-page":"224","DOI":"10.3389\/fncel.2018.00224","volume":"12","author":"C Gri\u00f1\u00e1n-Ferr\u00e9","year":"2018","unstructured":"Gri\u00f1\u00e1n-Ferr\u00e9 C, Izquierdo V, Otero E, Puigoriol-Illamola D, Corpas R, Sanfeliu C, et al. Environmental enrichment improves cognitive deficits, AD hallmarks and epigenetic alterations presented in 5xFAD mouse model. Front Cell Neurosci Front Cell Neurosci. 2018;12:224.","journal-title":"Front Cell Neurosci Front Cell Neurosci"},{"key":"794_CR42","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.jalz.2010.09.003","volume":"7","author":"MW Weiner","year":"2011","unstructured":"Weiner MW, Sadowsky C, Saxton J, Hofbauer RK, Graham SM, Yun S, et al. Magnetic resonance imaging and neuropsychological results from a trial of memantine in Alzheimer\u2019 s disease. Alzheimer\u2019s Dement. 2011;7:425\u201335.","journal-title":"Alzheimer\u2019s Dement"},{"key":"794_CR43","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1146\/annurev-physiol-030212-183711","volume":"75","author":"J Kumar","year":"2013","unstructured":"Kumar J, Mayer ML. Functional insights from glutamate receptor ion channel structures. Annu Rev Physiol. 2013;75:313\u201337.","journal-title":"Annu Rev Physiol"},{"key":"794_CR44","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.tins.2006.07.007","volume":"29","author":"G Lynch","year":"2006","unstructured":"Lynch G, Gall CM. Ampakines and the threefold path to cognitive enhancement. Trends Neurosci. 2006;29:554\u201362.","journal-title":"Trends Neurosci"},{"key":"794_CR45","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1007\/s00213-004-2065-6","volume":"4","author":"MD Black","year":"2005","unstructured":"Black MD. Therapeutic potential of positive AMPA modulators and their relationship to AMPA receptor subunits. A review of preclinical data. Psychopharmacol. 2005;4:154\u201363.","journal-title":"Psychopharmacol"},{"key":"794_CR46","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/j.1755-5949.2009.00088.x","volume":"16","author":"K Bernard","year":"2010","unstructured":"Bernard K, Danober L, Thomas J, Mu C, Cordi A, Desos P, et al. S 18986: A positive allosteric modulator of AMPA-type glutamate receptors pharmacological profile of a novel cognitive enhancer. CNS Neurosc Ther. 2010;16:193\u2013212.","journal-title":"CNS Neurosc Ther"},{"key":"794_CR47","doi-asserted-by":"crossref","first-page":"e0184429","DOI":"10.1371\/journal.pone.0184429","volume":"12","author":"S Bretin","year":"2017","unstructured":"Bretin S, Louis C, Seguin L, Wagner S, Thomas J-Y, Challal S, et al. Pharmacological characterisation of S 47445, a novel positive allosteric modulator of AMPA receptors. PLoS One. 2017;12:e0184429.","journal-title":"PLoS One."},{"key":"794_CR48","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.neuropharm.2017.06.009","volume":"123","author":"A Giralt","year":"2017","unstructured":"Giralt A, G\u00f3mez-Climent M\u00c1, Alcal\u00e1 R, Bretin S, Bertrand D, Mar\u00eda Delgado-Garc\u00eda J, et al. The AMPA receptor positive allosteric modulator S 47445 rescues in vivo CA3-CA1 long-term potentiation and structural synaptic changes in old mice. Neuropharmacology. 2017;123:395\u2013409.","journal-title":"Neuropharmacology"},{"key":"794_CR49","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1126\/science.1076358","volume":"298","author":"RJ Dolan","year":"2002","unstructured":"Dolan RJ. Emotion, cognition, and behavior. Science. 2002;298:1191\u20134.","journal-title":"Science."},{"key":"794_CR50","doi-asserted-by":"crossref","first-page":"M331","DOI":"10.1093\/gerona\/58.4.M331","volume":"58","author":"GT Grossberg","year":"2003","unstructured":"Grossberg GT, Desai AK. Management of Alzheimer\u2019s Disease. J Gerontol A Biol Sci Med Sci. 2003;58:M331\u201353.","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"794_CR51","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1126\/science.1202107","volume":"333","author":"D Refojo","year":"2011","unstructured":"Refojo D, Schweizer M, Kuehne C, Ehrenberg S, Thoeringer C, Vogl AM, et al. Glutamatergic and dopaminergic neurons mediate anxiogenic and anxiolytic effects of CRHR1. Science. 2011;333:1903\u20137.","journal-title":"Science"},{"key":"794_CR52","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1159\/000121334","volume":"25","author":"E Mossello","year":"2008","unstructured":"Mossello E, Boncinelli M, Caleri V, Cavallini MC, Palermo E, Di Bari M, et al. Is antidepressant treatment associated with reduced cognitive decline in Alzheimer\u2019s Disease? Dement Geriatr Cogn Disord. 2008;25:372\u20139.","journal-title":"Dement Geriatr Cogn Disord"},{"key":"794_CR53","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1016\/j.ajpath.2011.06.025","volume":"179","author":"T Jaworski","year":"2011","unstructured":"Jaworski T, Lechat B, Demedts D, Gielis L, Devijver H, Borghgraef P, et al. Dendritic degeneration, neurovascular defects, and inflammation precede neuronal loss in a mouse model for tau-mediated neurodegeneration. Am J Pathol. 2011;179:2001\u201315.","journal-title":"Am J Pathol"},{"key":"794_CR54","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1111\/j.1471-4159.2010.07058.x","volume":"115","author":"H Decker","year":"2010","unstructured":"Decker H, J\u00fcrgensen S, Adrover MF, Brito-Moreira J, Bomfim TR, Klein WL, et al. N-methyl-D-aspartate receptors are required for synaptic targeting of Alzheimer\u2019s toxic amyloid-\u03b2 peptide oligomers. J Neurochem. 2010;115:1520\u20139.","journal-title":"J Neurochem"},{"key":"794_CR55","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1074\/jbc.M115.666529","volume":"291","author":"T Miyamoto","year":"2016","unstructured":"Miyamoto T, Kim D, Knox JA, Johnson E, Mucke L. Increasing the receptor tyrosine kinase EphB2 prevents amyloid-\u03b2-induced depletion of cell surface glutamate receptors by a mechanism that requires the PDZ-binding motif of EphB2 and neuronal activity. J Biol Chem. 2016;291:1719\u201334. 22","journal-title":"J Biol Chem"},{"key":"794_CR56","doi-asserted-by":"crossref","first-page":"e12791","DOI":"10.1111\/acel.12791","volume":"17","author":"D Baglietto\u2010Vargas","year":"2018","unstructured":"Baglietto\u2010Vargas D, Prieto GA, Limon A, Forner S, Rodriguez\u2010Ortiz CJ, Ikemura K, et al. Impaired AMPA signaling and cytoskeletal alterations induce early synaptic dysfunction in a mouse model of Alzheimer\u2019s disease. Aging Cell. 2018;17:e12791.","journal-title":"Aging Cell."},{"key":"794_CR57","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.trci.2019.10.003","volume":"5","author":"H Tanaka","year":"2019","unstructured":"Tanaka H, Sakaguchi D, Hirano T. Amyloid-\u03b2 oligomers suppress subunit-specific glutamate receptor increase during LTP. Alzheimer\u2019s Dement. 2019;5:797\u2013808.","journal-title":"Alzheimer\u2019s Dement"},{"key":"794_CR58","doi-asserted-by":"crossref","first-page":"E6526","DOI":"10.1073\/pnas.1614249113","volume":"113","author":"NR Reinders","year":"2016","unstructured":"Reinders NR, Pao Y, Renner MC, Silva-Matos CM, da, Lodder TR, Malinow R, et al. Amyloid-\u03b2 effects on synapses and memory require AMPA receptor subunit GluA3. PNAS. 2016;113:E6526\u201334.","journal-title":"PNAS."},{"key":"794_CR59","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1016\/j.neurobiolaging.2014.03.031","volume":"35","author":"NC Berchtold","year":"2014","unstructured":"Berchtold NC, Sabbagh MN, Beach TG, Kim RC, Cribbs DH, Cotman CW. Brain gene expression patterns differentiate mild cognitive impairment from normal aged and Alzheimer disease. Neurobiol Aging. 2014;35:1961\u201372.","journal-title":"Neurobiol Aging."},{"key":"794_CR60","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1016\/j.ajpath.2012.06.033","volume":"181","author":"H-C Tai","year":"2012","unstructured":"Tai H-C, Serrano-Pozo A, Hashimoto T, Frosch MP, Spires-Jones TL, Hyman BT. The synaptic accumulation of hyperphosphorylated tau oligomers in Alzheimer disease is associated with dysfunction of the ubiquitin-proteasome system. Am J Pathol. 2012;181:1426\u201335.","journal-title":"Am J Pathol"},{"key":"794_CR61","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-016-0009-6","volume":"8","author":"L Zhou","year":"2017","unstructured":"Zhou L, McInnes J, Wierda K, Holt M, Herrmann AG, Jackson RJ, et al. Tau association with synaptic vesicles causes presynaptic dysfunction. Nat Commun. 2017;8:1\u201313.","journal-title":"Nat Commun."},{"key":"794_CR62","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.neuron.2018.01.022","volume":"97","author":"J McInnes","year":"2018","unstructured":"McInnes J, Wierda K, Snellinx A, Bounti L, Wang Y-C, Stancu I-C, et al. Synaptogyrin-3 mediates presynaptic dysfunction induced by Tau. Neuron. 2018;97:823\u2013835.e8.","journal-title":"Neuron."},{"key":"794_CR63","doi-asserted-by":"publisher","unstructured":"Borodovitsyna O, Flamini M, Chandler D. Noradrenergic modulation of cognition in health and disease. Neural Plast. 2017; 6031478.\u00a0https:\/\/doi.org\/10.1155\/2017\/6031478.","DOI":"10.1155\/2017\/6031478"},{"key":"794_CR64","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1515\/tnsci-2016-0007","volume":"7","author":"D \u0160vob \u0160trac","year":"2016","unstructured":"\u0160vob \u0160trac D, Pivac N, M\u00fcck-\u0160eler D. The serotonergic system and cognitive function. Transl Neurosci. 2016;7:35\u201349.","journal-title":"Transl Neurosci"},{"key":"794_CR65","doi-asserted-by":"crossref","first-page":"5006","DOI":"10.1523\/JNEUROSCI.3834-12.2013","volume":"33","author":"L Zhang","year":"2013","unstructured":"Zhang L, Ouyang M, Ganellin CR, Thomas SA. The slow afterhyperpolarization: a target of \u03b21-adrenergic signaling in hippocampus-dependent memory retrieval. J Neurosci. 2013;33:5006\u201316.","journal-title":"J Neurosci."},{"key":"794_CR66","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1097\/00001756-200207020-00021","volume":"13","author":"MKP Lai","year":"2002","unstructured":"Lai MKP, Tsang SWY, Francis PT, Keene J, Hope T, Esiri MM, et al. Postmortem serotoninergic correlates of cognitive decline in Alzheimer\u2019s disease. Neuroreport. 2002;13:1175\u20138.","journal-title":"Neuroreport."},{"key":"794_CR67","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.phrs.2017.04.019","volume":"121","author":"F Calabrese","year":"2017","unstructured":"Calabrese F, Savino E, Mocaer E, Bretin S, Racagni G, Riva MA. Upregulation of neurotrophins by S 47445, a novel positive allosteric modulator of AMPA receptors in aged rats. Pharm Res. 2017;121:59\u201369.","journal-title":"Pharm Res."},{"key":"794_CR68","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.neuropharm.2017.06.009","volume":"123","author":"A Giralt","year":"2017","unstructured":"Giralt A, G\u00f3mez-climent M\u00c1, Alcal\u00e1 R, Bretin S, Delgado-garc\u00eda JM, P\u00e9rez-navarro E, et al. The AMPA receptor positive allosteric modulator S 47445 rescues in vivo CA3-CA1 long-term potentiation and structural synaptic changes in old mice. Neuropharmacolgy. 2017;123:395\u2013409.","journal-title":"Neuropharmacolgy"},{"key":"794_CR69","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/S0140-6736(08)61075-2","volume":"372","author":"C Holmes","year":"2008","unstructured":"Holmes C, Boche D, Wilkinson D, Yadegarfar G, Hopkins V, Bayer A, et al. Long-term effects of abeta42 immunisation in Alzheimer\u2019s disease: follow-up of a randomised, placebo-controlled phase I trial. Lancet. 2008;372:216\u201323.","journal-title":"Lancet."},{"key":"794_CR70","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.trci.2019.04.002","volume":"5","author":"K Bernard","year":"2019","unstructured":"Bernard K, Gouttefangeas S, Bretin S, Galtier S, Robert P, Holthoff-Detto V, et al. A 24-week double-blind placebo-controlled study of the efficacy and safety of the AMPA modulator S47445 in patients with mild to moderate Alzheimer\u2019s disease and depressive symptoms. Alzheimers Dement (N. Y). 2019;5:231\u201340.","journal-title":"Alzheimers Dement (N. Y)"}],"container-title":["Molecular Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41380-020-0794-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41380-020-0794-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41380-020-0794-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,13]],"date-time":"2022-01-13T19:15:15Z","timestamp":1642101315000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41380-020-0794-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,28]]},"references-count":70,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["794"],"URL":"https:\/\/doi.org\/10.1038\/s41380-020-0794-5","relation":{},"ISSN":["1359-4184","1476-5578"],"issn-type":[{"value":"1359-4184","type":"print"},{"value":"1476-5578","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,28]]},"assertion":[{"value":"1 December 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"This study was partly financially supported by the Institut de Recherches Internationales Servier (France) which has no influence on the experimental performance, tissue collection, and analysis as well as data analysis. SB and FA and RB are employees of Institut de Recherches Internationales Servier.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}